Chlamydia pneumoniae aggravates vein graft intimal hyperplasia in a rat model

BMC Microbiology

Volumn 7, Issue , 2007, Pages

  Kloppenburg, Geoffrey T L ^a   De Graaf, Rick ^a   Grauls, Gert E L M ^a   Bruggeman, Cathrien A ^a   Stassen, Frank R ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; HEAT SHOCK PROTEIN 60;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL PROLIFERATION; CHLAMYDOPHILA PNEUMONIAE; CONTROLLED STUDY; DISEASE EXACERBATION; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MALE; MORPHOMETRICS; NONHUMAN; RAT; SMOOTH MUSCLE FIBER; T LYMPHOCYTE; VEIN DISEASE; VEIN GRAFT DISEASE; VEIN INTIMA HYPERPLASIA; ANIMAL; AUTOTRANSPLANTATION; BACTERIAL INFECTION; GRAFT OCCLUSION; HYPERPLASIA; ILIAC VEIN; INTIMA; LEWIS RAT; PATHOLOGY; TRANSPLANTATION;

ANGINA; ANIMALIA; CHLAMYDOPHILA PNEUMONIAE; RATTUS;

ANIMALS; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; GRAFT OCCLUSION, VASCULAR; HYPERPLASIA; ILIAC VEIN; IMMUNOHISTOCHEMISTRY; MALE; MODELS, ANIMAL; MYOCYTES, SMOOTH MUSCLE; RATS; RATS, INBRED LEW; TRANSPLANTATION, AUTOLOGOUS; TUNICA INTIMA;

EID: 38849208525     PISSN: 14712180     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/1471-2180-7-111     Document Type: Article

References (28)

1. Stranger in a strange land: the pathogenesis of saphenous vein graft stenosis with emphasis on structural and functional differences between veins and arteries. JL Cox DA Chiasson AI Gotlieb, Prog Cardiovasc Dis 1991 34 45 68 10.1016/0033-0620(91)90019-I 2063013
2. Coronary artery bypass graft disease. ON Nwasokwa, Ann Intern Med 1995 123 528 45 7661498
3. Integrity of vein grafts as a function of initial intimal and medial preservation. FW LoGerfo WC Quist NL Cantelmo CC Haudenschild, Circulation 1983 68 II117 24 6872181
4. Association of chlamydial infection with cerebrovascular disease. ML Wimmer R Sandmann-Strupp P Saikku RL Haberl, Stroke 1996 27 2207 10 8969782
5. Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. P Saikku K Mattila MS Nieminen JK Huttunen M Leinonen M-R Ekman PH Mäkelä V Valtonen, Lancet 1988 332 983 6 10.1016/S0140-6736(88)90741-6
6. Chlamydophila pneumoniae (Chlamydia pneumoniae) accelerates the formation of complex atherosclerotic lesions in Apo E3-Leiden mice. R Ezzahiri HJ Nelissen-Vrancken HA Kurvers FR Stassen I Vliegen GE Grauls MM van Pul PJ Kitslaar CA Bruggeman, Cardiovasc Res 2002 56 269 76 10.1016/S0008-6363(02) 00544-8 12393097
7. Chlamydia pneumoniae and atherosclerosis: does the evidence support a causal or contributory role? JB Mahony BK Coombes, FEMS Microbiol Lett 2001 197 1 9 10.1111/j.1574-6968.2001.tb10574.x 11287138
8. Chlamydia pneumoniae - an infectious risk factor for atherosclerosis? LA Campbell CC Kuo, Nat Rev Microbiol 2004 2 23 32 10.1038/nrmicro796 15035006
9. Chlamydia pneumoniae infection promotes a proliferative phenotype in the vasculature through Egr-1 activation in vitro and in vivo. J Rupp T Hellwig-Burgel V Wobbe U Seitzer E Brandt M Maass, Proc Natl Acad Sci USA 2005 102 3447 3452 15722416 10.1073/pnas.0407759102
10. Chlamydia pneumoniae stimulates proliferation of vascular smooth muscle cells through induction of endogenous heat shock protein 60. S Hirono E Dibrov C Hurtado A Kostenuk R Ducas GN Pierce, Circ Res 2003 93 710 716 10.1161/01.RES.0000095720.46043.F2 14500333
11. Association of serology with the endovascular presence of Chlamydia pneumoniae and cytomegalovirus in coronary artery and vein graft disease. C Bartels M Maas G Bein N Brill JF Bechtel R Leyh HH Sievers, Circulation 2000 101 137 141 10637199
12. Detection of Chlamydia pneumoniae DNA in the coronary arteries and bypass in three patients with diffuse coronary artery disease. M Zorc O Vraspir-Porenta D Kese D Petrovic M Legan, Cardiology 2005 103 121 122 10.1159/000083436 15665532
13. Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells. P Calabro JT Willerson ET Yeh, Circulation 2003 108 1930 1932 10.1161/01.CIR.0000096055.62724.C5 14530191
14. C-reactive protein: risk marker or mediator in atherothrombosis? I Jialal S Devaraj SK Venugopal, Hypertension 2004 44 6 11 10.1161/01.HYP.0000130484. 20501.df 15148294
15. Human heat shock protein 60 stimulates vascular smooth muscle cell proliferation through Toll-like receptors 2 and 4. R de Graaf G Kloppenburg PJ Kitslaar CA Bruggeman F Stassen, Microbes Infect 2006 8 1859 1865 10.1016/j.micinf.2006.02.024 16843693
16. Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years. GM Fitzgibbon HP Kafka AJ Leach WJ Keon GD Hooper JR Burton, J Am Coll Cardiol 1996 28 616 626 10.1016/0735-1097(96)00206-9 8772748
17. Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention. GJ Motwani EJ Topol, Circulation 1998 97 916 931 9521341
18. Macrophage depletion alters vein graft intimal hyperplasia. JR Hoch VK Stark N van Rooijen JL Kim MP Nutt TF Warner, Surgery 1999 126 428 37 10455917
19. Chlamydia pneumoniae burden in carotid arteries is associated with upregulation of plaque interleukin-6 and elevated C-reactive protein in serum. SC Johnston H Zhang LM Messina MT Lawton D Dean, Arterioscler Thromb Vasc Biol 2005 25 2648 2653 10.1161/01.ATV.0000189157.88630.d1 16210572
20. Chlamydia pneumoniae DNA in the arterial wall of patients with peripheral vascular disease. J Gutierrez J Linares-Palomino C Lopez-Espada M Rodriguez E Ros G Piedrola MC del Maroto, Infection 2001 29 196 200 10.1007/s15010-001-1180- 0 11545479
21. Detection of Chlamydia pneumoniae but not cytomegalovirus in occluded saphenous vein coronary artery bypass grafts. C Bartels M Maas G Bein R Malisius N Brill JF Bechtel F Sayk AC Feller HH Sievers, Circulation 1999 99 879 882 10027809
22. Growth of Chlamydia pneumoniae in cultured human peripheral blood mononuclear cells and induction of a cytokine response. SS Kaukoranta-Tolvanen AM Teppo K Laitinen P Saikku K Linnavuori M Leinonen, Microb Pathog 1996 21 215 221 10.1006/mpat.1996.0056 8878018
23. Toll-like receptor 2 mediates persistent chemokine release by Chlamydia pneumoniae-infected vascular smooth muscle cells. X Yang D Coriolan K Schultz DT Golenbock D Beasley, Arterioscler Thromb Vasc Biol 2005 25 2308 2314 10.1161/01.ATV.0000187468.00675.a3 16179594
24. C-reactive protein induces tissue factor expression and promotes smooth muscle and endothelial cell proliferation. P Cirillo P Golino P Calabro G Cali M Ragni S De Rosa G Cimmino M Pacileo R De Palma L Forte A Gargiulo FG Corigliano V Angri R Spagnuolo L Nitsch M Chiariello, Cardiovasc Res 2005 68 47 55 10.1016/j.cardiores.2005.05.010 16023093
25. Role of chlamydial heat shock protein 60 in the stimulation of innate immune cells by Chlamydia pneumoniae. CP Costa CJ Kirschning D Busch S Durr L Jennen U Heinzmann S Prebeck H Wagner T Miethke, Eur J Immunol 2000 32 2460 70 10.1002/1521-4141(200209)32:9<2460::AID-IMMU2460>3.0.CO;2-M
26. Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophages. A Kol T Bourcier AH Lichtman P Libby, J Clin Invest 1999 103 571 7 10021466
27. Chlamydia pneumoniae and chlamydial heat shock protein 60 stimulate proliferation of human vascular smooth muscle cells via toll-like receptor 4 and p44/p42 mitogen-activated protein kinase activation. S Sasu D LaVerda N Qureshi DT Golenbock D Beasley, Circ Res 2001 89 244 50 10.1161/hh1501.094184 11485974
28. Vein graft intimal hyperplasia: leukocytes and cytokine gene expression. JR Hoch VK Stark DA Hullett WD Turnipseed, Surgery 116 463 470 8048012